Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 5Stomach Neoplasms 2Warts 1Stomatitis 1Shock, Septic 1Pain, Postoperative 1Neoplasms 1Melanoma 1Lymphedema 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Emergence Delirium 1Disease 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × Methylene Blue × Clear all
NCT07147452 2025-08-29

SLN_GC_SPIO

Hospital del SAS de Jerez

Active not recruiting
44 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03049345 2019-09-06

Gastric Cancer Sentinel Lymph Node Mapping

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡